You searched for "blind"
CHEC announces national online CPD event covering critical eye condition that has seen 400% increase in secondary care referrals
CHEC announces national online CPD event covering critical eye condition that has seen 400% increase in secondary care referrals. The seminar is to be hosted by CHEC Clinical Director Mahmoud Rabie and follows the UK rollout of CHEC’s ground-breaking YAG Quantel Capsulo Laser System which significantly improves accuracy in eye treatments.Booster accelerates EU-funded projects results to create tangible impact
META Group is proud to announce that Booster has been renewed for another four years, with additional and customised services. Funded by the European Commission’s Directorate-General for Research and Innovation (DG RTD) and led by META Group, Booster offers a...Specsavers Launches brand new Roblox Obby
Specsavers has unveiled the ‘Specsavers Obby’, a new branded obstacle course game and virtual merchandise giveaway on Roblox, marking the high-street retailer’s commitment to educating younger generations and continued steps into the gaming space.Glaucoma UK’s World Glaucoma Week campaign to increase awareness of glaucoma risk factors
16 March 2023
World Glaucoma Week is an annual initiative which brings health organisation and charities from around the world together to amplify health messages relating to glaucoma and raise awareness of the disease.
Making the most of your foundation year rotation in ophthalmology
18 June 2025
| Rohan Aziz
|
EYE - General
Ophthalmology continues to be a highly desirable speciality in the UK; however, medical students usually encounter only minimal exposure, generally ranging from one to two weeks, during their studies [1]. Nevertheless, eye-related conditions represent a considerable share of presentations in...
Persistence of Ebola virus in ocular fluid during convalescence
1 August 2015
| Jonathan CP Roos
|
EYE - Vitreo-Retinal
The most recent Ebola outbreak has infected over 26,300 patients, but also resulted in the highest number of survivors in history. Uveitis has been described during the convalescent period, but Varkey and colleagues report, for the first time, finding viable...
Thrombophilia in patients with retinal vein occlusion
1 December 2014
| Sofia Rokerya
|
EYE - Vitreo-Retinal
The authors present a retrospective study of the prevalence of thrombophilia in patients with retinal vein occlusion. The study cohort included 88 patients with central retinal vein occlusion (CRVO), 51 patients with branch retinal vein occlusion (BRVO) and 40 controls....
Association between serum triglycerides and pan retinal photocoagulation in type 1 diabetes
1 December 2013
| Khadijah Basheer
|
EYE - Glaucoma
This retrospective cohort study aimed to examine whether dyslipidaemia is a risk factor for progressing to proliferative diabetic retinopathy (PDR) and consequently requiring pan retinal photocoagulation (PRP) treatment in type 1 diabetics. In previous studies including the ETDRS study an...
Current concepts of the uveitis-glaucoma-hyphaema (UGH) syndrome
The authors discuss pathophysiology, aetiology and current management strategies of UGH syndrome. The clinical features of UGH are different than initial descriptions. UGH today is most often associated with posterior chamber IOLs that are not placed within the capsular bag...
Is intracranial pressure affected by the valsalva manoeuvres and exercise?
31 May 2024
| Claire Howard
|
EYE - Neuro-ophthalmology
Idiopathic intracranial hypertension (IIH) is characterised by elevated intracranial pressure (ICP), which leads to optic nerve head swelling and a risk of visual loss. The impact of straining and exercise on ICP regulation is poorly understood yet clinically relevant to...
College insight: RCOphth Annual Congress 2024
The Royal College of Ophthalmologists share with Eye News some insights to 2024's annual congress.Mainline Instruments Appoints Jeff Landucci as Commercial Director - Ophthalmic Therapeutics
27 February 2025
|
Recruitment & Personnel
Mainline Instruments is pleased to announce the appointment of Jeff Landucci as its new Commercial Director of Ophthalmic Therapeutics, effective February 28, 2025. Well known industry veteran, Landucci will join the senior management team and play a key role in...
